A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats.

@article{Malanka2015ARO,
  title={A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats.},
  author={Tomasz Maślanka},
  journal={Veterinary journal},
  year={2015},
  volume={203 3},
  pages={
          278-84
        }
}
Glaucoma is a heterogeneous group of disorders usually associated with elevated intraocular pressure (IOP), leading to optic nerve damage, retinal ganglion cell death and irreversible vision loss. Therefore, medications that lower IOP are the mainstay of glaucoma therapy. Carbonic anhydrase inhibitors (CAIs) are some of the principal drugs used in the management of canine and feline glaucoma. This paper summarises current knowledge of the mechanism of action of these agents and their effect on… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

A comparative study of the effects of brinzolamide and 775 dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with 776 primary open - angle glaucoma

B. Siesky, A. Harris, +6 authors R. Ehrlich
  • British Journal of Ophthalmology
  • 2008

Antimicrobials , anti - inflammatory agents , and antiglaucoma drugs

A. Regnier
  • Veterinary Ophthalmology
  • 2007

Similar Papers

Loading similar papers…